Sanofi CEO Paul Hudson joins 'Squawk Box' to discuss the company's quarterly earnings results, Blueprint acquisition, strong ...

Sanofi CEO Paul Hudson joins 'Squawk Box' to discuss the company's quarterly earnings results, 2025 outlook, drug pipeline, the company's dividend and buyback decision, his thoughts on the ...

Now, Hudson's goal is it to secure a Republican seat. "My approach all along has been this right here, 'Paul for All,' and I think we need to get back to a more unifying style of leadership.

On just his 100th day as Sanofi's CEO, Paul Hudson has reviewed the business and laid out his vision for the future. | Sanofi spent months hyping its Tuesday investor event, and new CEO Paul ...

Sanofi CEO Paul Hudson speaks during the Competing In The Global Marketplace: Strategies for Growth panel, at the Fortune Global Forum on Nov. 11, 2024 in New York City. (Jemal Countess—Getty ...

PARIS—Sanofi’s newly installed CEO Paul Hudson asked journalists to turn an objective eye on the company—and, presumably, him—as he tunes up strategy, sets priorities and generally figures ...

Paul Hudson, meanwhile, raised about $209,000 and ended with about $342,000 in the bank, according to his campaign finance report. That quarterly fundraising total includes a March 27 loan of ...

At Sanofi, where he took the helm last fall, Hudson has done just that—and quite publicly. He hit pause on a partnership with Google's Verily business, dubbed Onduo, announced with great fanfare ...

Paul Hudson is CEO of the French pharmaceutical company Sanofi which is currently partnering on the development of two potential vaccines for COVID-19. Hudson took over as Sanofi’s CEO last year ...